Highly purified mussel adhesive protein to secure biosafety for in vivo applications

Bong-Hyuk Choi; Hogyun Cheong; Yun Kee Jo; So Yeong Bahn; Jeong Hyun Seo; Hyung Joon Cha
April 2014
Microbial Cell Factories;2014, Vol. 13 Issue 1, p1
Academic Journal
Background Unique adhesive and biocompatibility properties of mussel adhesive proteins (MAPs) are known for their great potential in many tissue engineering and biomedical applications. Previously, it was successfully demonstrated that redesigned hybrid type MAP, fp-151, mass-produced in Gram-negative bacterium Escherichia coli, could be utilized as a promising adhesive biomaterial. However, purification of recombinant fp-151 has been unsatisfactory due to its adhesive nature and polarity which make separation of contaminants (especially, lipopolysaccharide, a toxic Gram-negative cell membrane component) very difficult. Results In the present work, we devised a high resolution purification approach to secure safety standards of recombinant fp-151 for the successful use in in vivo applications. Undesirable impurities were remarkably eliminated as going through sequential steps including treatment with multivalent ion and chelating agent for cell membrane washing, mechanical cell disruption, non-ionic surfactant treatment for isolated inclusion body washing, acid extraction of washed inclusion body, and ion exchange chromatography purification of acid extracted sample. Through various analyses, such as high performance liquid chromatographic purity assay, limulus amoebocyte lysate endotoxin assay, and in vitro mouse macrophage cell tests on inflammation, viability, cytotoxicity, and apoptosis, we confirmed the biological safety of bacterial-derived purified recombinant fp-151. Conclusions Through this purification design, recombinant fp-151 achieved 99.90% protein purity and 99.91% endotoxin reduction that nearly no inflammation response was observed in in vitro experiments. Thus, the highly purified recombinant MAP would be successfully used as a safety-secured in vivo bioadhesive for tissue engineering and biomedical applications.


Related Articles

  • Is the C-terminal insertional signal in Gram-negative bacterial outer membrane proteins species-specific or not? Paramasivam, Nagarajan; Habeck, Michael; Linke, Dirk // BMC Genomics;2012, Vol. 13 Issue 1, p1 

    Background: In Gram-negative bacteria, the outer membrane is composed of an asymmetric lipid bilayer of phopspholipids and lipopolysaccharides, and the transmembrane proteins that reside in this membrane are almost exclusively β-barrel proteins. These proteins are inserted into the membrane...

  • Optimization and Efficient Purification in Production of Brucella melitensis Recombinant HSP and TF Proteins With Low Endotoxin Contents. Ghasemi, Amir; Salari, Mohammad Hossein; Pourmand, Mohammad Reza; Zarnani, Amir Hassan; Ahmadi, Hojat; Shirazi, Mohamad Hassan; Jeddi-Tehrani, Mahmood // Jundishapur Journal of Microbiology;Sep2013, Vol. 6 Issue 7, p1 

    Background: The development of an effective subunit vaccine against brucellosis is a research area of intense. But optimization of recombinant proteins production in Escherichia coli and content of endotoxins associated with final recombinant proteins are very important. Objectives: In the...

  • A Comparison of the Effects of Endotoxin Upon Fibroblast Proliferation and Macromolecular Syntheses. SINGER, R. E.; DUTTON, W. G. // Journal of Dental Research;Jun1979, Vol. 58 Issue 6, p1634 

    The effects of Escherichia coli endotoxin upon mouse L929 cell proliferation, DNA synthesis, protein synthesis, and proline incorporation were determined. It was found that a level of endotoxin which inhibited cell proliferation prompted a similar inhibition of DNA synthesis and overall cell...

  • Molecular basis of voltage gating of OmpF porin. Robertson, Kindal M; Tieleman, D Peter // Biochemistry & Cell Biology;Oct2002, Vol. 80 Issue 5, p517 

    OmpF and PhoE from Escherichia coli and related homologous proteins from other Gram-negative bacteria allow the passive transport of small polar molecules across the bacterial outer membrane. In vitro, they exhibit voltage gating depending on the experimental conditions. We review current...

  • Structural biology: POTRA domains close up. Molloy, Sheilagh // Nature Reviews Microbiology;Oct2007, Vol. 5 Issue 10, p747 

    The article focuses on the study about the Gram-negative bacteria's outer, protein membrane. The study discusses the processes of how protein crosses or inserts itself in the bacteria's membrane. It also describes the structure of a polypeptide-transport-associated (POTRA) domain through the...

  • In-Field Implementation of a Recombinant Factor C Assay for the Detection of Lipopolysaccharide as a Biomarker of Extant Life within Glacial Environments. Barnett, Megan J.; Wadham, Jemma L.; Jackson, Miriam; Cullen, David C. // Biosensors (2079-6374);Mar2012, Vol. 2 Issue 1, p83 

    The discovery over the past two decades of viable microbial communities within glaciers has promoted interest in the role of glaciers and ice sheets (the cryosphere) as contributors to subglacial erosion, global biodiversity, and in regulating global biogeochemical cycles. In situ or in-field...

  • Time to stop horsing around? Kabrick, Holly // Laboratory News;Jul2015, p22 

    The article discusses the methods used to detect endotoxins or lipopolysaccharide complexes associated with the outer membrane of Gram-negative bacteria. Topics covered include the importance of screening pharmaceuticals to avoid endotoxin contamination, the advantages of using gel cloth assay...

  • Genomic characterization of JG068, a novel virulent podovirus active against Burkholderia cenocepacia. Lynch, Karlene H.; Abdu, Ashraf H.; Schobert, Max; Dennis, Jonathan J. // BMC Genomics;2013, Vol. 14 Issue 1, p1 

    Background: As is true for many other antibiotic-resistant Gram-negative pathogens, members of the Burkholderia cepacia complex (BCC) are currently being assessed for their susceptibility to phage therapy as an antimicrobial treatment. The objective of this study was to perform genomic and...

  • Pre-treatment with antibiotics and Escherichia coli to equalize the gut microbiota in conventional mice. Linninge, Caroline; Ahrné, Siv; Molin, Göran // Antonie van Leeuwenhoek;Jan2015, Vol. 107 Issue 1, p149 

    The composition of the gut microbiota can vary widely between individual mice of the same batch and thereby affect the resulting outcome in experimental studies. Therefore, an efficient method is needed to equalize the gut microbiota prior to the start of critical experiments. In order to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics